SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001047469-17-005445
Filing Date
2017-08-29
Accepted
2017-08-29 17:25:33
Documents
10

Document Format Files

Seq Description Document Type Size
1 S-3 a2233100zs-3.htm S-3 235807
2 EX-5.1 a2233100zex-5_1.htm EX-5.1 32926
3 EX-23.1 a2233100zex-23_1.htm EX-23.1 3568
4 EX-23.2 a2233100zex-23_2.htm EX-23.2 3422
5 G147237.JPG g147237.jpg GRAPHIC 24018
6 G209762KGI001.JPG g209762kgi001.jpg GRAPHIC 1862
7 G209762KGI002.JPG g209762kgi002.jpg GRAPHIC 1858
8 G566233.JPG g566233.jpg GRAPHIC 17257
9 G346302.JPG g346302.jpg GRAPHIC 3823
10 G998995.JPG g998995.jpg GRAPHIC 21661
  Complete submission text file 0001047469-17-005445.txt   374709
Mailing Address 201 MISSION STREET, SUITE 2375 SAN FRANCISCO CA 94105
Business Address 201 MISSION STREET, SUITE 2375 SAN FRANCISCO CA 94105 415-896-5081
Jaguar Health, Inc. (Filer) CIK: 0001585608 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-220236 | Film No.: 171058766
SIC: 2834 Pharmaceutical Preparations